Takeda receives $38m grant to help eradicate polio
Takeda has received $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries.
With this funding, Takeda will develop, license and supply at least 50 million doses per year of Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries. The vaccine will be manufactured at Takeda’s facility in Hikari, Japan.
Click on this link for more information.